01Overview 02Daily Brief 03Live 04Congress 05Corporate Insiders 06Government Money 07Political Influence 08Institutions 09Washington Network 10Follow the Power 11Disclosure Clock 12AI Investigator 13Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Methodology Match review Launch readiness

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…

Overview Daily Brief Live Congress Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Methodology Match review Launch readiness

01Overview 02Daily Brief 03Live 04Congress 05Corporate Insiders 06Government Money 07Political Influence 08Institutions 09Washington Network 10Follow the Power 11Disclosure Clock 12AI Investigator 13Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Methodology Match review Launch readiness

Overview Daily Brief Live Congress Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Methodology Match review Launch readiness

Data sources

SEC FORM 44h ago

HOUSE PTR4h ago

SEC 13F4h ago

ROBINHOOD CHAIN4h ago

Public company

ALVOAlvotech

CIK 0001898416

EDGAR filings Open in network

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections3with evidence

ALVO · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
← Lobbied forevidence
HOLLAND & KNIGHT LLPLDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
← Lobbied forevidence
CGCN GROUP, LLCLDA RR 2026 third quarter · Health issues, MAN, TAR · Aug 26, 2026

Lobbying

$50K reported · de-duplicated

2026 Q3 $0 via firms2026 Q2 $0 via firms2026 Q1 $50K via firms

HOLLAND & KNIGHT LLP—2026 Q2 · posted Aug 26, 2026 ·
HOLLAND & KNIGHT LLP$50K2026 Q1 · posted Aug 26, 2026 · Trade
CGCN GROUP, LLC—2026 Q3 · posted Aug 26, 2026 · Health issues, MAN, TAR

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.